ELITechGroup announces CE-IVD marking of ELITe InGenius

ELITechGroup Molecular Diagnostics and Precision System Science, Co., Ltd (PSS), a leading global provider of laboratory instruments for nucleic acid extraction, jointly announced the upcoming CE-IVD marking of ELITe InGenius for IVD applications in Europe and the upcoming availability of the instrument as Laboratory Use Equipment in the US.

Photo: ELITechGroup announces CE-IVD marking of ELITe InGenius

"The launch of the ELITe InGenius system is a major step forward in our strategy to offer global solutions for Molecular Diagnostics. In partnership with PSS, we have taken advantage of decades of development expertise in molecular diagnostics chemistry and our proprietary real-time PCR menu to develop and validate a complete sample-to-result solution for infectious disease testing." said Christoph Gauer, CEO of ELITechGroup.

ELITe InGenius automatically performs all the steps of molecular diagnostics including extraction, amplification and result analysis. 1 to 12 samples can be processed with greater flexibility offering the possibility to potentially mix any kind of sample matrices within the same run and perform multiple and independent PCR even with completely diverse thermal profiles simply on demand. In addition, each of the 12 real-time PCR thermal cyclers is equipped with 6-optical channels, supplemented when appropriate with melt-curve analysis to provide extended multiplexing capability. The system is enabled with a unique real-time PCR menu based on ELITechGroup’s proven MGB technology, providing a rapid introduction of CE-IVD infectious disease menu for transplant monitoring and Healthcare Acquired Infections. The versatile system can also be used as an open platform running laboratory developed tests or other tests of interest.

"The ELITe InGenius is a real breakthrough for molecular diagnostics. It combines unique capabilities not available on other sample-to-result systems, like universal extraction, storage of extracted nucleic acid and multiple and independently controlled RT PCR with multiplexing capabilities, offering to the laboratory an unprecedented flexibility and assay menu possibility" said Christoph Gauer.

Source: ELITechGroup


Read all latest stories

Related articles


Article • Research

Genetic alterations

This article discusses examples of applications of genetic analyses in coagulation disorders and haematological and oncological diseases. Professor Christine Mannhalter highlights the impact changes…


Article • Cancer diagnostics II

New nanoparticle could enhance MRI scanning

Scientists in the UK have designed a new self-assembling nano­particle that targets tumours and could lead to quicker diagnosis of cancer. Researchers at Imperial College London report that a new…


News • Molecular and immunofluorescence imaging

Orion: A new tool for diagnosing cancer

Researchers at Harvard Medical School developed a new tool that promises to improve the way pathologists see and evaluate a tumor by providing detailed clues about the cancer.

Related products

Subscribe to Newsletter